Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226,316 | 239,142 | 243,348 | 266,269 | 286,470 |
| Marketable Securities | 50,083 | 50,276 | 49,994 | 44,875 | 49,943 |
| Receivables | 34,903 | 31,988 | 35,993 | 35,354 | 44,064 |
| Inventories | 24,078 | 28,484 | 30,376 | 30,863 | 32,063 |
| TOTAL | $346,776 | $361,831 | $371,869 | $390,231 | $424,256 |
| Non-Current Assets | |||||
| PPE Net | 102,520 | 106,339 | 121,339 | 126,225 | 131,830 |
| Investments And Advances | 1,525 | 0 | 0 | 0 | 0 |
| Intangibles | 100,289 | 100,552 | 137,709 | 139,001 | 140,294 |
| Other Non-Current Assets | 63,213 | 69,396 | 71,929 | 77,358 | 80,023 |
| TOTAL | $267,547 | $276,287 | $330,977 | $342,584 | $352,147 |
| Total Assets | $614,323 | $638,118 | $702,846 | $732,815 | $776,403 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,630 | 6,626 | 7,703 | 9,256 | 14,052 |
| Accrued Expenses | 48,754 | 46,497 | 39,727 | 34,746 | 36,572 |
| Other current liabilities | 5,817 | 6,079 | 5,439 | 6,418 | 7,803 |
| TOTAL | $71,006 | $73,757 | $67,490 | $65,228 | $73,323 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 70,628 | 73,222 | 75,225 | 77,545 | 79,648 |
| TOTAL | $70,628 | $73,222 | $75,225 | $77,545 | $79,648 |
| Total Liabilities | $141,634 | $146,979 | $142,715 | $142,773 | $152,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,356 | 58,586 | 58,226 | 57,818 | 57,674 |
| Retained earnings | -1,241,908 | -1,207,253 | -1,121,682 | -1,076,190 | -1,033,034 |
| Other shareholders' equity | -522 | -735 | -660 | -565 | -756 |
| TOTAL | $472,689 | $491,139 | $560,131 | $590,042 | $623,432 |
| Total Liabilities And Equity | $614,323 | $638,118 | $702,846 | $732,815 | $776,403 |